| 期 |
栏目 |
标题 |
文件 |
| 卷 79, 编号 3 (2004) |
Editorial |
Obliterating bronchiolytis induced by D-penicillamine in a female patient with systemic sclerosis |
|
| 卷 79, 编号 11 (2004) |
Editorial |
Exacerbated chronic obstructive pulmonary disease: current trends in diagnosis and treatment (review) |
|
| 卷 80, 编号 8 (2008) |
Editorial |
Is it possible to modify the course of chronic obstructive pulmonary disease with modern medication? |
|
| 卷 81, 编号 3 (2009) |
Editorial |
Thiotropium in bronchial asthma |
|
| 卷 83, 编号 3 (2011) |
Editorial |
Determination of clinical phenotypes of chronic obstructive pulmonary disease a new treatment approach |
|
| 卷 83, 编号 9 (2011) |
Editorial |
Pandemic flu in Russia: special features of a clinical course and the absence of early etiotropic therapy as a risk factor of severe forms of the disease |
|
| 卷 84, 编号 3 (2012) |
Editorial |
SECONDARY PULMONARY HYPERTENSION: SOME ASPECTS OF PATHOGENESIS |
|
| 卷 84, 编号 3 (2012) |
Editorial |
ORGANIZING PNEUMONIA: DIAGNOSIS AND TREATMENT |
|
| 卷 84, 编号 3 (2012) |
Editorial |
THE ROLE OF ENDOTHELIAL DYSFUNCTION AND ARTERIAL RIGIDITY IN PATHOGENESIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
|
| 卷 84, 编号 4 (2012) |
Editorial |
CURRENT RECOMMENDATIONS ON DIAGNOSIS AND TREATMENT OF PULMONARY ARTERIAL HYPERTENSION |
|
| 卷 84, 编号 12 (2012) |
Editorial |
Current guidelines for oxygen therapy in emergency care |
|
| 卷 85, 编号 3 (2013) |
Editorial |
First clinical experience with endothelin receptor antagonist bosentan used in patients with pulmonary hypertension: results of a one-year study |
|
| 卷 86, 编号 3 (2014) |
Editorial |
Choice of novel endpoints in clinical trials evaluating the efficiency of drug therapy in patients with pulmonary hypertension |
|
| 卷 86, 编号 9 (2014) |
Editorial |
Clinical guidelines for the diagnosis and treatment of pulmonary hypertension |
|
| 卷 86, 编号 10 (2014) |
Editorial |
The 2013-2014 epidemic season. Hospital monitoring and antiviral therapy for influenza |
|
| 卷 87, 编号 9 (2015) |
Editorial |
Approaches to therapy for pulmonary hypertension: Role of the endothelin receptor antagonist bosentan |
|
| 卷 88, 编号 7 (2016) |
Editorial |
The new endothelin receptor antagonist macitentan: Prospects for therapy of pulmonary arterial hypertension |
(Rus)
|
| 卷 88, 编号 8 (2016) |
Editorial |
Expert Panel Resolution on Personified Choice of an Inhaler in Patients with Asthma and Chronic Obstructive Pulmonary Diseas |
(Rus)
|
| 卷 89, 编号 1 (2017) |
Editorial |
Idiopatic pulmonary fibrosis: A new paradigm |
(Rus)
|
| 卷 89, 编号 9 (2017) |
Editorial |
A patient with severe idiopathic pulmonary arterial hypertension: Is there a way out? |
(Rus)
|
| 卷 90, 编号 3 (2018) |
Editorial |
Combination therapy is a new standard for treatment of pulmonary arterial hypertension |
(Rus)
|
| 卷 90, 编号 12 (2018) |
Editorial |
Treatment of exacerbations of chronic obstructive pulmonary disease |
(Rus)
|
| 卷 91, 编号 3 (2019) |
Editorial |
New opportunities of dual bronchodilation therapy for patients with chronic obstructive pulmonary disease |
(Rus)
|
| 卷 91, 编号 3 (2019) |
Editorial |
Possibilities of ultrasound research of the diaphragm |
(Rus)
|
| 卷 91, 编号 9 (2019) |
Editorial |
Risk stratification methods and their significance in pulmonary arterial hypertension |
(Rus)
|
| 卷 91, 编号 10 (2019) |
Editorial |
Eosinophilic inflammation in chronic obstructive pulmonary disease |
(Rus)
|
| 卷 91, 编号 12 (2019) |
Editorial |
Clinical and economic analysis of Reslizumab use in the treatment of patients with severe allergic eosinophilic asthma |
(Rus)
|
| 卷 92, 编号 1 (2020) |
Editorial |
The concept of chronic obstructive pulmonary disease clinical control as a decision - making tool in real clinical practice for optimizing of basic pharmacotherapy |
(Rus)
|
